| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.32e-08 | 20 | 210 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.01e-07 | 37 | 210 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.23e-07 | 38 | 210 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.89e-06 | 36 | 210 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.36e-05 | 50 | 210 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.92e-05 | 53 | 210 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 TBC1D9B RGPD1 RGPD3 EIF2B5 DOCK6 RIC1 RGPD5 RGPD2 RANBP2 RGPD8 KALRN RAPGEF4 ASAP3 ARHGEF1 DOCK7 ARHGEF2 | 2.77e-05 | 507 | 210 | 17 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 TBC1D9B RGPD1 RGPD3 EIF2B5 DOCK6 RIC1 RGPD5 RGPD2 RANBP2 RGPD8 KALRN RAPGEF4 ASAP3 ARHGEF1 DOCK7 ARHGEF2 | 2.77e-05 | 507 | 210 | 17 | GO:0030695 |
| GeneOntologyMolecularFunction | valine-tRNA ligase activity | 1.10e-04 | 2 | 210 | 2 | GO:0004832 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 PDE6C PDE8A ERVK-7 PLA2G4D PP2D1 PLA2G12B PTPRS PLD2 VARS1 PPP4R1 MTMR8 PIWIL4 VARS2 GDPD4 PIKFYVE RNASE4 ARSF ERVK-8 GPCPD1 GEN1 | 1.28e-04 | 807 | 210 | 21 | GO:0016788 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.78e-04 | 11 | 210 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.83e-04 | 14 | 210 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | myo-inositol transmembrane transporter activity | 6.51e-04 | 4 | 210 | 2 | GO:0005365 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 USP34 ERVK-7 SPPL2B C2 ERVK-19 ERVK-25 USP6 SPPL2A PREP ERVK-8 PRSS50 ESPL1 | 6.59e-04 | 430 | 210 | 13 | GO:0004175 |
| GeneOntologyMolecularFunction | GTPase activator activity | RGPD4 TBC1D9B RGPD1 RGPD3 RGPD5 RGPD2 RANBP2 RGPD8 ASAP3 ARHGEF1 | 7.72e-04 | 279 | 210 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | isomerase activity | 9.93e-04 | 192 | 210 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | ADGRG5 IL13RA1 HCAR2 KIR2DS2 ADGRG4 ADRB3 PIGR PKD1 OR1E2 ADGRF5 TACR1 KIR2DL3 ADGRF1 LPAR4 HTR5A GPR35 OR10Q1 ADGRL1 GABBR2 LGR5 MILR1 OR12D3 EGFR TLR5 TAS1R1 KIR3DL3 MARCO | 1.01e-03 | 1353 | 210 | 27 | GO:0004888 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.33e-03 | 21 | 210 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SCN11A PKD1L2 PANX3 KCNK15 PKD1 GPM6A TPCN2 KCNAB2 SLC5A1 SLC5A11 SLC39A12 ATP2B1 KCNAB3 | 1.34e-03 | 465 | 210 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.37e-03 | 46 | 210 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.47e-03 | 79 | 210 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 USP34 ERVK-7 SPPL2B C2 ERVK-19 ERVK-25 USP50 CPE USP6 SPPL2A PREP ERVK-8 PRSS50 LTA4H ESPL1 | 1.56e-03 | 654 | 210 | 16 | GO:0008233 |
| GeneOntologyMolecularFunction | glycerophosphodiester phosphodiesterase activity | 1.61e-03 | 6 | 210 | 2 | GO:0008889 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.10e-11 | 20 | 209 | 8 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 8.25e-11 | 9 | 209 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.05e-10 | 10 | 209 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.63e-09 | 13 | 209 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.83e-09 | 14 | 209 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 ERVK-6 RGPD1 KPNA6 NUP205 MDN1 RGPD3 PKD1 AKT1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 SPG11 SMG5 THOC3 | 3.38e-07 | 378 | 209 | 17 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 ERVK-6 RGPD1 KPNA6 NUP205 MDN1 RGPD3 PKD1 AKT1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 SPG11 SMG5 THOC3 | 3.38e-07 | 378 | 209 | 17 | GO:0006913 |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SLC35C2 SMG5 THOC3 ABCC6 EPG5 | 1.66e-06 | 249 | 209 | 13 | GO:0015931 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMG5 THOC3 ATM | 2.11e-06 | 178 | 209 | 11 | GO:0051236 |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 2.12e-06 | 38 | 209 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | mRNA transport | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMG5 THOC3 | 2.31e-06 | 145 | 209 | 10 | GO:0051028 |
| GeneOntologyBiologicalProcess | nuclear export | RGPD4 ERVK-6 RGPD1 MDN1 RGPD3 PKD1 RGPD2 RANBP2 RGPD8 SMG5 THOC3 | 3.07e-06 | 185 | 209 | 11 | GO:0051168 |
| GeneOntologyBiologicalProcess | protein import into nucleus | RGPD4 RGPD1 KPNA6 RGPD3 AKT1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 SPG11 | 5.10e-06 | 195 | 209 | 11 | GO:0006606 |
| GeneOntologyBiologicalProcess | import into nucleus | RGPD4 RGPD1 KPNA6 RGPD3 AKT1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 SPG11 | 6.81e-06 | 201 | 209 | 11 | GO:0051170 |
| GeneOntologyBiologicalProcess | RNA transport | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMG5 THOC3 | 1.23e-05 | 175 | 209 | 10 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMG5 THOC3 | 1.23e-05 | 175 | 209 | 10 | GO:0050657 |
| GeneOntologyBiologicalProcess | RNA localization | RGPD4 ERVK-6 RGPD1 NUP205 RGPD3 RGPD2 RANBP2 RGPD8 SMG5 THOC3 ATM | 1.40e-05 | 217 | 209 | 11 | GO:0006403 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.73e-05 | 54 | 209 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 EMC1 RGPD1 SREBF2 KPNA6 RGPD3 AKT1 MFSD1 PLRG1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 KALRN SZT2 FKRP MIS18A RAPGEF4 OBSL1 SPG11 CPE PIKFYVE HOOK3 MACF1 FBXW7 | 4.54e-05 | 1091 | 209 | 26 | GO:0033365 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 6.11e-05 | 132 | 209 | 8 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 6.80e-05 | 134 | 209 | 8 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 8.34e-05 | 71 | 209 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 RGPD1 KPNA6 RGPD3 AKT1 PLRG1 HEATR3 RGPD5 RGPD2 RANBP2 RGPD8 SPG11 PIKFYVE | 8.76e-05 | 362 | 209 | 13 | GO:0034504 |
| GeneOntologyBiologicalProcess | transport of virus | 9.28e-05 | 24 | 209 | 4 | GO:0046794 | |
| GeneOntologyBiologicalProcess | response to host | 1.02e-04 | 2 | 209 | 2 | GO:0075136 | |
| GeneOntologyBiologicalProcess | valyl-tRNA aminoacylation | 1.02e-04 | 2 | 209 | 2 | GO:0006438 | |
| GeneOntologyBiologicalProcess | response to host defenses | 1.02e-04 | 2 | 209 | 2 | GO:0052200 | |
| GeneOntologyBiologicalProcess | response to defenses of other organism | 1.02e-04 | 2 | 209 | 2 | GO:0052173 | |
| GeneOntologyBiologicalProcess | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.35e-04 | 49 | 209 | 5 | GO:0031146 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.49e-04 | 191 | 209 | 9 | GO:0007189 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | ADGRG5 ADGRG4 ADRB3 ADGRF5 ADGRF1 HTR5A RAPGEF4 ADGRL1 GABBR2 LGR5 MARCO | 1.70e-04 | 286 | 209 | 11 | GO:0007188 |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis of virus by host cell | 2.11e-04 | 12 | 209 | 3 | GO:0019065 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 ERVK-6 RGPD1 KPNA6 MYO5C NUP205 DST MDN1 AP5Z1 RGPD3 PKD1 AKT1 HEATR3 RIC1 RGPD5 RGPD2 RANBP2 TPCN2 RGPD8 MYO19 SPG11 SMG5 THOC3 EPG5 PIKFYVE HOOK3 DOCK7 DYNC1LI1 ARHGEF2 HPS5 | 2.57e-04 | 1496 | 209 | 30 | GO:0046907 |
| GeneOntologyBiologicalProcess | DNA integration | 2.72e-04 | 13 | 209 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | endocytosis involved in viral entry into host cell | 3.44e-04 | 14 | 209 | 3 | GO:0075509 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CUL9 TUBGCP2 DNAAF5 DST PKD1 PKHD1 SPAG16 TBCE OBSL1 SLC39A12 HOOK3 ARHGEF1 DNAH17 DOCK7 DYNC1LI1 ARHGEF2 ESPL1 GEN1 | 4.07e-04 | 720 | 209 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | establishment of organelle localization | SCN11A MYO5C MDN1 PKD1 PKHD1 PLD2 MAP4K2 MYO19 SPG11 MILR1 HOOK3 DOCK7 ATM ARHGEF2 ESPL1 | 4.75e-04 | 546 | 209 | 15 | GO:0051656 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 6.03e-04 | 231 | 209 | 9 | GO:0006109 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 6.05e-04 | 4 | 209 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | response to high light intensity | 6.05e-04 | 4 | 209 | 2 | GO:0009644 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 6.05e-04 | 4 | 209 | 2 | GO:0140213 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.56e-11 | 8 | 209 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.89e-10 | 10 | 209 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.61e-09 | 14 | 209 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.56e-08 | 18 | 209 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.21e-08 | 20 | 209 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.45e-08 | 21 | 209 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 7.96e-06 | 101 | 209 | 8 | GO:0005643 | |
| GeneOntologyCellularComponent | inclusion body | 2.88e-04 | 90 | 209 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | basal part of cell | DST PKD1 MAP4K2 CA11 RAPGEF4 SLC1A5 ABCC6 SLC22A9 SLC16A6 EGFR DOCK7 ATP2B1 | 4.45e-04 | 378 | 209 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 PDE8A RGPD1 NELL1 DST RGPD3 PKHD1 DOCK6 RGPD2 RANBP2 RGPD8 KALRN PKP4 OBSL1 SLC5A1 EPG5 TG PIKFYVE SLC39A12 EGFR FBXW7 | 4.62e-04 | 934 | 209 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | SCF ubiquitin ligase complex | 6.80e-04 | 70 | 209 | 5 | GO:0019005 | |
| GeneOntologyCellularComponent | basal plasma membrane | DST PKD1 MAP4K2 CA11 RAPGEF4 SLC1A5 ABCC6 SLC22A9 SLC16A6 EGFR ATP2B1 | 9.12e-04 | 354 | 209 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 1.36e-03 | 212 | 209 | 8 | GO:0031461 | |
| GeneOntologyCellularComponent | Cul4B-RING E3 ubiquitin ligase complex | 1.45e-03 | 6 | 209 | 2 | GO:0031465 | |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 RGPD1 NUP205 NELL1 DST RGPD3 PLRG1 RGPD5 RGPD2 RANBP2 RGPD8 DTL MTMR8 EGFR | 1.58e-03 | 560 | 209 | 14 | GO:0005635 |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.38e-08 | 16 | 158 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 3.62e-07 | 26 | 158 | 6 | MP:0012058 | |
| MousePheno | abnormal preimplantation embryo morphology | RGPD4 RGPD1 TUBGCP2 ATAD3C RGPD3 TAF5 RGPD2 RANBP2 RGPD8 MIS18A THOC3 PIKFYVE EGFR ESPL1 ATP2B1 | 7.46e-07 | 283 | 158 | 15 | MP:0014137 |
| MousePheno | decreased tumor latency | 8.99e-07 | 30 | 158 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.10e-06 | 31 | 158 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.96e-06 | 34 | 158 | 6 | MP:0010307 | |
| MousePheno | abnormal energy expenditure | RGPD4 ACER1 FNDC5 RGPD1 DIP2A RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 CPE MBOAT4 OR12D3 TLR5 | 2.62e-06 | 313 | 158 | 15 | MP:0005450 |
| MousePheno | abnormal energy homeostasis | RGPD4 ACER1 FNDC5 RGPD1 DIP2A RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 CPE MBOAT4 OR12D3 TLR5 | 3.71e-06 | 322 | 158 | 15 | MP:0005448 |
| MousePheno | increased hepatobiliary system tumor incidence | 4.53e-06 | 111 | 158 | 9 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 4.53e-06 | 111 | 158 | 9 | MP:0008019 | |
| MousePheno | abnormal blastocyst formation | 4.54e-06 | 39 | 158 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 5.39e-06 | 61 | 158 | 7 | MP:0004024 | |
| MousePheno | abnormal susceptibility to weight gain | RGPD4 FNDC5 RGPD1 DIP2A ADRB3 RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 MBOAT4 OR12D3 TLR5 | 1.09e-05 | 309 | 158 | 14 | MP:0011117 |
| MousePheno | abnormal chromosome morphology | 1.28e-05 | 126 | 158 | 9 | MP:0003702 | |
| MousePheno | increased hepatocellular carcinoma incidence | 1.36e-05 | 70 | 158 | 7 | MP:0003331 | |
| MousePheno | decreased susceptibility to diet-induced obesity | RGPD4 RGPD1 RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 MBOAT4 OR12D3 | 1.36e-05 | 160 | 158 | 10 | MP:0005659 |
| MousePheno | increased energy expenditure | RGPD4 ACER1 RGPD1 RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 MBOAT4 OR12D3 | 1.39e-05 | 196 | 158 | 11 | MP:0004889 |
| MousePheno | abnormal mitosis | 1.45e-05 | 128 | 158 | 9 | MP:0004046 | |
| MousePheno | enlarged epididymis | 1.60e-05 | 99 | 158 | 8 | MP:0004931 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | RGPD4 RGPD1 NUP205 RGPD3 PLRG1 RGPD2 RANBP2 RGPD8 DTL PIKFYVE ATP2B1 | 1.93e-05 | 203 | 158 | 11 | MP:0011094 |
| MousePheno | increased sarcoma incidence | 1.99e-05 | 102 | 158 | 8 | MP:0002032 | |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 RGPD1 TUBGCP2 NUP205 EFTUD2 DNAAF5 ATAD3C RGPD3 TAF5 PLRG1 RGPD2 RANBP2 RGPD8 FKRP DTL OBSL1 THOC3 PIKFYVE EGFR SUDS3 MACF1 ESPL1 ATP2B1 | 2.17e-05 | 779 | 158 | 23 | MP:0014257 |
| MousePheno | abnormal hippocampus pyramidal cell morphology | 4.27e-05 | 57 | 158 | 6 | MP:0009940 | |
| MousePheno | abnormal cell nucleus morphology | 4.54e-05 | 184 | 158 | 10 | MP:0003111 | |
| MousePheno | absent estrus | 4.80e-05 | 7 | 158 | 3 | MP:0009021 | |
| MousePheno | decreased susceptibility to weight gain | RGPD4 RGPD1 RGPD3 AKT1 AKT2 RGPD2 RANBP2 RGPD8 MBOAT4 OR12D3 | 4.98e-05 | 186 | 158 | 10 | MP:0010182 |
| MousePheno | abnormal chromosome number | 5.25e-05 | 86 | 158 | 7 | MP:0004023 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 RGPD1 TUBGCP2 NUP205 EFTUD2 DNAAF5 ATAD3C RGPD3 TAF5 PLRG1 RGPD2 RANBP2 RGPD8 DTL OBSL1 THOC3 PIKFYVE EGFR SUDS3 MACF1 ESPL1 ATP2B1 | 5.66e-05 | 772 | 158 | 22 | MP:0014259 |
| MousePheno | embryonic lethality before implantation | RGPD4 RGPD1 NUP205 RGPD3 PLRG1 RGPD2 RANBP2 RGPD8 DTL PIKFYVE ATP2B1 | 9.58e-05 | 242 | 158 | 11 | MP:0006204 |
| MousePheno | abnormal hippocampus pyramidal cell layer | 1.48e-04 | 71 | 158 | 6 | MP:0008284 | |
| MousePheno | increased respiratory system tumor incidence | 2.09e-04 | 107 | 158 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 2.09e-04 | 107 | 158 | 7 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 2.09e-04 | 107 | 158 | 7 | MP:0003694 | |
| MousePheno | biliary cyst | 2.19e-04 | 11 | 158 | 3 | MP:0003266 | |
| MousePheno | increased lung carcinoma incidence | 2.49e-04 | 78 | 158 | 6 | MP:0008714 | |
| MousePheno | abnormal blastocyst hatching | 2.92e-04 | 113 | 158 | 7 | MP:0003693 | |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RGPD1 FBXL4 DST AP5Z1 RGPD3 RGPD2 RANBP2 TPCN2 RGPD8 SPG11 EPG5 SUDS3 ATM CTNND1 ESPL1 | 4.60e-04 | 546 | 158 | 16 | MP:0014239 |
| MousePheno | abnormal extrahepatic bile duct morphology | 4.71e-04 | 14 | 158 | 3 | MP:0009498 | |
| MousePheno | dilated bile duct | 5.83e-04 | 15 | 158 | 3 | MP:0003253 | |
| MousePheno | abnormal epididymis size | 5.95e-04 | 166 | 158 | 8 | MP:0004926 | |
| MousePheno | abnormal hippocampus layer morphology | 6.07e-04 | 92 | 158 | 6 | MP:0000813 | |
| MousePheno | abnormal preimplantation embryo development | 7.23e-04 | 171 | 158 | 8 | MP:0009781 | |
| Domain | Ran_BP1 | 1.18e-11 | 12 | 202 | 7 | PF00638 | |
| Domain | RANBD1 | 1.18e-11 | 12 | 202 | 7 | PS50196 | |
| Domain | RanBD | 2.53e-11 | 13 | 202 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 2.53e-11 | 13 | 202 | 7 | IPR000156 | |
| Domain | Grip | 6.56e-10 | 11 | 202 | 6 | SM00755 | |
| Domain | GRIP | 6.56e-10 | 11 | 202 | 6 | PF01465 | |
| Domain | GRIP_dom | 1.30e-09 | 12 | 202 | 6 | IPR000237 | |
| Domain | GRIP | 1.30e-09 | 12 | 202 | 6 | PS50913 | |
| Domain | Rab_bind | 2.91e-09 | 7 | 202 | 5 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.91e-09 | 7 | 202 | 5 | IPR032023 | |
| Domain | - | 3.40e-08 | 10 | 202 | 5 | 1.10.220.60 | |
| Domain | GPS | 6.55e-08 | 34 | 202 | 7 | SM00303 | |
| Domain | GPS | 8.12e-08 | 35 | 202 | 7 | PF01825 | |
| Domain | GPS | 9.98e-08 | 36 | 202 | 7 | PS50221 | |
| Domain | GPS | 1.22e-07 | 37 | 202 | 7 | IPR000203 | |
| Domain | WD40_repeat_dom | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 HPS5 FBXW7 | 1.57e-07 | 297 | 202 | 16 | IPR017986 |
| Domain | WD40_repeat_CS | CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 WDR88 DTL TBL3 FBXW7 | 2.30e-07 | 164 | 202 | 12 | IPR019775 |
| Domain | G-protein_beta_WD-40_rep | 3.43e-07 | 85 | 202 | 9 | IPR020472 | |
| Domain | WD_REPEATS_1 | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 FBXW7 | 3.80e-07 | 278 | 202 | 15 | PS00678 |
| Domain | WD_REPEATS_2 | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 FBXW7 | 3.98e-07 | 279 | 202 | 15 | PS50082 |
| Domain | WD_REPEATS_REGION | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 FBXW7 | 3.98e-07 | 279 | 202 | 15 | PS50294 |
| Domain | - | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 HPS5 FBXW7 | 7.27e-07 | 333 | 202 | 16 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 RIC1 WDR88 DTL THOC3 TBL3 HPS5 FBXW7 | 7.87e-07 | 335 | 202 | 16 | IPR015943 |
| Domain | WD40 | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 WDR88 DTL THOC3 TBL3 FBXW7 | 1.38e-06 | 268 | 202 | 14 | SM00320 |
| Domain | WD40_repeat | WDR64 CORO2B NWD2 TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 WDR88 DTL THOC3 TBL3 FBXW7 | 1.64e-06 | 272 | 202 | 14 | IPR001680 |
| Domain | ARM-type_fold | USP34 SAAL1 CUL9 KPNA6 DNAAF5 EIF2B5 HEATR3 PPP4R1 PKP4 BTAF1 MROH1 INTS4 LTA4H ATM CTNND1 | 4.49e-06 | 339 | 202 | 15 | IPR016024 |
| Domain | WD40 | WDR64 CORO2B TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 WDR88 DTL THOC3 TBL3 FBXW7 | 5.13e-06 | 259 | 202 | 13 | PF00400 |
| Domain | - | SAAL1 CUL9 KPNA6 DNAAF5 AP5Z1 HEATR3 PPP4R1 PKP4 BTAF1 MROH1 INTS4 CTNND1 | 5.62e-06 | 222 | 202 | 12 | 1.25.10.10 |
| Domain | ig | KIR2DS2 PIGR PTPRS ADGRF5 KIR2DL2 KIR2DL3 TMIGD2 MYOM3 OBSL1 KIR3DL3 SIGLEC1 | 7.27e-06 | 190 | 202 | 11 | PF00047 |
| Domain | Immunoglobulin | KIR2DS2 PIGR PTPRS ADGRF5 KIR2DL2 KIR2DL3 TMIGD2 MYOM3 OBSL1 KIR3DL3 SIGLEC1 | 7.27e-06 | 190 | 202 | 11 | IPR013151 |
| Domain | DMAP_binding | 1.23e-05 | 5 | 202 | 3 | PF06464 | |
| Domain | HEAT | 1.25e-05 | 48 | 202 | 6 | PF02985 | |
| Domain | PH_dom-like | RGPD4 RGPD1 RGPD3 AKT1 AKT2 PLD2 RGPD5 RGPD2 RANBP2 RGPD8 KALRN MTMR8 ASAP3 GRB14 ARHGEF1 ARHGEF2 | 1.68e-05 | 426 | 202 | 16 | IPR011993 |
| Domain | DMAP1-bd | 2.43e-05 | 6 | 202 | 3 | IPR010506 | |
| Domain | DMAP_binding | 2.43e-05 | 6 | 202 | 3 | SM01137 | |
| Domain | - | RGPD4 RGPD1 RGPD3 AKT1 AKT2 PLD2 RGPD2 RANBP2 RGPD8 KALRN MTMR8 ASAP3 GRB14 ARHGEF1 ARHGEF2 | 2.44e-05 | 391 | 202 | 15 | 2.30.29.30 |
| Domain | HEAT | 3.77e-05 | 58 | 202 | 6 | IPR000357 | |
| Domain | ARM-like | SAAL1 CUL9 KPNA6 DNAAF5 AP5Z1 HEATR3 PPP4R1 PKP4 BTAF1 MROH1 INTS4 CTNND1 | 3.96e-05 | 270 | 202 | 12 | IPR011989 |
| Domain | GPCR_2_extracellular_dom | 6.81e-05 | 40 | 202 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 6.81e-05 | 40 | 202 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 6.81e-05 | 40 | 202 | 5 | PS50227 | |
| Domain | HEAT_REPEAT | 1.10e-04 | 70 | 202 | 6 | PS50077 | |
| Domain | Valyl-tRNA_ligase | 1.16e-04 | 2 | 202 | 2 | IPR002303 | |
| Domain | Anticodon_Ia_Val | 1.16e-04 | 2 | 202 | 2 | IPR033705 | |
| Domain | 7tm_2 | 2.01e-04 | 50 | 202 | 5 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.01e-04 | 50 | 202 | 5 | PS00650 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB-rel | 3.47e-04 | 3 | 202 | 2 | IPR005399 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB | 3.47e-04 | 3 | 202 | 2 | IPR005983 | |
| Domain | GPCR_2_secretin-like | 4.75e-04 | 60 | 202 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 4.75e-04 | 60 | 202 | 5 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 5.13e-04 | 61 | 202 | 5 | PS50261 | |
| Domain | Ig-like_fold | IL13RA1 FNDC5 KIR2DS2 PIGR PTPRS PKHD1 ADGRF5 KIR2DL2 KIR2DL3 KALRN TMIGD2 MYOM3 OBSL1 MILR1 KIR3DL3 GPCPD1 ASTN1 SIGLEC1 | 6.82e-04 | 706 | 202 | 18 | IPR013783 |
| Domain | GPCR_2_Ig-hepta-like_rcpt | 6.88e-04 | 4 | 202 | 2 | IPR008078 | |
| Domain | REJ | 6.88e-04 | 4 | 202 | 2 | PS51111 | |
| Domain | REJ_dom | 6.88e-04 | 4 | 202 | 2 | IPR014010 | |
| Domain | IG | KIR2DS2 PIGR PTPRS ADGRF5 KIR2DL2 KIR2DL3 KALRN TMIGD2 MYOM3 OBSL1 MILR1 KIR3DL3 SIGLEC1 | 6.95e-04 | 421 | 202 | 13 | SM00409 |
| Domain | Ig_sub | KIR2DS2 PIGR PTPRS ADGRF5 KIR2DL2 KIR2DL3 KALRN TMIGD2 MYOM3 OBSL1 MILR1 KIR3DL3 SIGLEC1 | 6.95e-04 | 421 | 202 | 13 | IPR003599 |
| Domain | HEAT_type_2 | 7.58e-04 | 17 | 202 | 3 | IPR021133 | |
| Domain | F-box | 7.90e-04 | 67 | 202 | 5 | PF00646 | |
| Domain | - | IL13RA1 FNDC5 KIR2DS2 PIGR PTPRS PKHD1 ADGRF5 KIR2DL2 KIR2DL3 KALRN TMIGD2 MYOM3 OBSL1 MILR1 GPCPD1 ASTN1 SIGLEC1 | 9.03e-04 | 663 | 202 | 17 | 2.60.40.10 |
| Domain | FBOX | 1.10e-03 | 72 | 202 | 5 | PS50181 | |
| Domain | Peptidase_A22B_SPP | 1.14e-03 | 5 | 202 | 2 | IPR007369 | |
| Domain | Gal_Lectin | 1.14e-03 | 5 | 202 | 2 | PF02140 | |
| Domain | Lectin_gal-bd_dom | 1.14e-03 | 5 | 202 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 1.14e-03 | 5 | 202 | 2 | PS50228 | |
| Domain | Peptidase_A22B | 1.14e-03 | 5 | 202 | 2 | PF04258 | |
| Domain | TPR-contain_dom | 1.25e-03 | 150 | 202 | 7 | IPR013026 | |
| Domain | F-box-like | 1.29e-03 | 44 | 202 | 4 | PF12937 | |
| Domain | F-box_dom | 1.32e-03 | 75 | 202 | 5 | IPR001810 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.70e-03 | 6 | 202 | 2 | PS51460 | |
| Domain | PQQ_repeat | 1.70e-03 | 6 | 202 | 2 | IPR002372 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | PF02187 | |
| Domain | DUF3398 | 1.70e-03 | 6 | 202 | 2 | PF11878 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 1.70e-03 | 6 | 202 | 2 | IPR009008 | |
| Domain | PKD/REJ-like | 1.70e-03 | 6 | 202 | 2 | IPR002859 | |
| Domain | Anticodon_1 | 1.70e-03 | 6 | 202 | 2 | PF08264 | |
| Domain | REJ | 1.70e-03 | 6 | 202 | 2 | PF02010 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.30.920.20 | |
| Domain | DOCK_C/D_N | 1.70e-03 | 6 | 202 | 2 | IPR021816 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 1.70e-03 | 6 | 202 | 2 | IPR013155 | |
| Domain | - | 1.70e-03 | 6 | 202 | 2 | 3.90.740.10 | |
| Domain | GAS_dom | 1.70e-03 | 6 | 202 | 2 | IPR003108 | |
| Domain | GAS2 | 1.70e-03 | 6 | 202 | 2 | SM00243 | |
| Domain | Spectrin | 1.88e-03 | 23 | 202 | 3 | PF00435 | |
| Domain | TPR_REGION | 2.15e-03 | 165 | 202 | 7 | PS50293 | |
| Domain | TPR | 2.15e-03 | 165 | 202 | 7 | PS50005 | |
| Domain | aa-tRNA-synth_Ia | 2.36e-03 | 7 | 202 | 2 | IPR002300 | |
| Domain | GP_PDE_dom | 2.36e-03 | 7 | 202 | 2 | IPR030395 | |
| Domain | PSN | 2.36e-03 | 7 | 202 | 2 | SM00730 | |
| Domain | Plectin | 2.36e-03 | 7 | 202 | 2 | PF00681 | |
| Domain | GlyceroP-diester-Pdiesterase | 2.36e-03 | 7 | 202 | 2 | IPR004129 | |
| Domain | tRNA-synt_1 | 2.36e-03 | 7 | 202 | 2 | PF00133 | |
| Domain | GDPD | 2.36e-03 | 7 | 202 | 2 | PF03009 | |
| Domain | Plectin_repeat | 2.36e-03 | 7 | 202 | 2 | IPR001101 | |
| Domain | Plakophilin/d_Catenin | 2.36e-03 | 7 | 202 | 2 | IPR028435 | |
| Domain | Preselin/SPP | 2.36e-03 | 7 | 202 | 2 | IPR006639 | |
| Domain | GP_PDE | 2.36e-03 | 7 | 202 | 2 | PS51704 | |
| Domain | PLEC | 2.36e-03 | 7 | 202 | 2 | SM00250 | |
| Domain | FBOX | 2.40e-03 | 52 | 202 | 4 | SM00256 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 2.19e-08 | 18 | 150 | 6 | MM1549 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.67e-07 | 58 | 150 | 8 | MM14736 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.86e-07 | 40 | 150 | 7 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.23e-07 | 41 | 150 | 7 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.65e-07 | 42 | 150 | 7 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.14e-07 | 43 | 150 | 7 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.91e-07 | 47 | 150 | 7 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.93e-07 | 49 | 150 | 7 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 9.14e-07 | 50 | 150 | 7 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.05e-06 | 51 | 150 | 7 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.78e-06 | 55 | 150 | 7 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.56e-06 | 58 | 150 | 7 | MM15149 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.59e-06 | 86 | 150 | 8 | MM15413 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.58e-06 | 65 | 150 | 7 | MM15147 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.96e-06 | 92 | 150 | 8 | MM14951 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.22e-05 | 73 | 150 | 7 | MM14948 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 1.53e-05 | 15 | 150 | 4 | M48306 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 2.62e-05 | 82 | 150 | 7 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.06e-05 | 84 | 150 | 7 | MM14929 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 6.36e-05 | 8 | 150 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 6.36e-05 | 8 | 150 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 6.36e-05 | 8 | 150 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 6.36e-05 | 8 | 150 | 3 | M47498 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 6.40e-05 | 21 | 150 | 4 | M184 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 9.40e-05 | 100 | 150 | 7 | MM14561 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 9 | 150 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 9.46e-05 | 9 | 150 | 3 | M47481 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.34e-04 | 10 | 150 | 3 | M47400 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.79e-04 | 27 | 150 | 4 | M27422 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.83e-04 | 11 | 150 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 1.83e-04 | 11 | 150 | 3 | M47501 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.14e-04 | 114 | 150 | 7 | MM15361 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 2.42e-04 | 12 | 150 | 3 | M47393 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.51e-04 | 117 | 150 | 7 | MM15387 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.72e-04 | 30 | 150 | 4 | MM15170 | |
| Pathway | WP_GPCRS_ODORANT | 2.74e-04 | 157 | 150 | 8 | MM15872 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 3.94e-04 | 14 | 150 | 3 | M47536 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.54e-04 | 129 | 150 | 7 | MM14894 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 4.89e-04 | 15 | 150 | 3 | M47389 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | RGPD4 RGPD1 DST RGPD3 PLD2 DOCK6 RGPD2 RANBP2 RGPD8 KALRN MYO19 PKP4 SLC1A5 ARHGEF1 DOCK7 DYNC1LI1 ARHGEF2 | 5.42e-04 | 649 | 150 | 17 | MM15690 |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 5.54e-04 | 96 | 150 | 6 | M16121 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 5.57e-04 | 36 | 150 | 4 | MM15339 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 6.19e-04 | 37 | 150 | 4 | M27641 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 6.31e-04 | 65 | 150 | 5 | M15 | |
| Pathway | PID_TELOMERASE_PATHWAY | 7.25e-04 | 67 | 150 | 5 | M105 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | RGPD4 RGPD1 NUP205 EFTUD2 RGPD3 PLRG1 RGPD2 RANBP2 RGPD8 THOC3 | 7.63e-04 | 277 | 150 | 10 | MM15414 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.73e-04 | 141 | 150 | 7 | MM15266 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 8.97e-04 | 234 | 150 | 9 | MM14898 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.07e-03 | 193 | 150 | 8 | MM14890 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 1.10e-03 | 5 | 150 | 2 | M48999 | |
| Pathway | REACTOME_NEDDYLATION | 1.24e-03 | 245 | 150 | 9 | M27822 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.44e-03 | 202 | 150 | 8 | MM15362 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 1.57e-03 | 22 | 150 | 3 | M13897 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 1.62e-03 | 80 | 150 | 5 | M6121 | |
| Pathway | BIOCARTA_EEA1_PATHWAY | 1.64e-03 | 6 | 150 | 2 | MM1577 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 1.64e-03 | 6 | 150 | 2 | M47523 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 1.70e-03 | 119 | 150 | 6 | M48309 | |
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 9037092 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 21205196 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 24403063 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 23536549 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 12191015 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 3.52e-13 | 7 | 214 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 3.52e-13 | 7 | 214 | 6 | 11353387 | |
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 30944974 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 3.52e-13 | 7 | 214 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 3.52e-13 | 7 | 214 | 6 | 17372272 | |
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 38657106 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 18949001 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 25187515 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 8603673 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 26632511 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 23818861 | ||
| Pubmed | 3.52e-13 | 7 | 214 | 6 | 20682751 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.40e-12 | 8 | 214 | 6 | 21670213 | |
| Pubmed | 1.40e-12 | 8 | 214 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.40e-12 | 8 | 214 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.40e-12 | 8 | 214 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.40e-12 | 8 | 214 | 6 | 28745977 | |
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 28100513 | ||
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 17887960 | ||
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 4.18e-12 | 9 | 214 | 6 | 18394993 | |
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 11553612 | ||
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 10601307 | ||
| Pubmed | 4.18e-12 | 9 | 214 | 6 | 28877029 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.04e-11 | 10 | 214 | 6 | 16332688 | |
| Pubmed | 1.04e-11 | 10 | 214 | 6 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.04e-11 | 10 | 214 | 6 | 8857542 | |
| Pubmed | 1.04e-11 | 10 | 214 | 6 | 21859863 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | USP34 TBC1D9B CUL9 SPPL2B STK11IP DIP2A EHBP1L1 DST MDN1 PTPRS PKD1 AKT1 AKT2 DOCK6 RIC1 KALRN SZT2 MTMR8 MYOM3 ADGRL1 BTAF1 SMG5 SLC1A5 NR2F2 DHX30 PIKFYVE MROH1 DIP2C ARHGEF2 ESPL1 | 1.07e-11 | 1105 | 214 | 30 | 35748872 |
| Pubmed | 2.28e-11 | 11 | 214 | 6 | 17069463 | ||
| Pubmed | 2.28e-11 | 11 | 214 | 6 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 2.28e-11 | 11 | 214 | 6 | 35771867 | |
| Pubmed | 4.77e-11 | 22 | 214 | 7 | 27717094 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 8.37e-11 | 13 | 214 | 6 | 31427429 | |
| Pubmed | 2.42e-10 | 15 | 214 | 6 | 14697343 | ||
| Pubmed | RGPD4 NES RGPD1 EFTUD2 DST MDN1 PTPRS RGPD3 TAF5 GPM6A DIP2B RGPD2 RANBP2 RGPD8 KALRN PKP4 RAPGEF4 KCNAB2 GABBR2 KANK2 HOOK3 DOCK7 MACF1 CTNND1 ARHGEF2 | 1.61e-09 | 963 | 214 | 25 | 28671696 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 EMC1 RGPD1 KPNA6 NUP205 EFTUD2 MDN1 RGPD3 TMX3 PLRG1 WDR77 VARS1 RGPD5 RGPD2 RANBP2 RGPD8 DTL BTAF1 HNRNPUL1 THOC3 SLC1A5 TBL3 LGALS3BP DHX30 EEF1G NFXL1 DYNC1LI1 CTNND1 | 4.59e-09 | 1257 | 214 | 28 | 37317656 |
| Pubmed | EMC1 SREBF2 DIP2A DST EIF2B5 PLRG1 HEATR3 RIC1 PPP4R1 DIP2B MYO19 PKP4 OBSL1 BTAF1 ARHGEF1 ASB3 DOCK7 NFXL1 ARHGEF2 HPS5 | 4.63e-09 | 650 | 214 | 20 | 38777146 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TBC1D9B SAAL1 EMC1 SREBF2 KPNA6 TUBGCP2 NUP205 DNAAF5 EIF2B5 TMX3 VARS1 HEATR3 RANBP2 FKRP DTL OBSL1 BTAF1 SLC1A5 TBL3 ARHGEF1 NFXL1 DYNC1LI1 ARHGEF2 ESPL1 | 5.02e-09 | 942 | 214 | 24 | 31073040 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES EMC1 NUP205 EFTUD2 EHBP1L1 NWD2 DST DOCK6 PLRG1 VARS1 DIP2B RANBP2 SRSF4 KALRN HNRNPUL1 THOC3 DHX30 EEF1G DOCK7 DYNC1LI1 INTS4 MACF1 ATM ARHGEF2 CATSPERG | 1.62e-08 | 1082 | 214 | 25 | 38697112 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP34 EMC1 FNDC5 KPNA6 NUP205 DNAAF5 PTPRS TMEM131L PLD2 TMX3 WDR77 VARS1 DIP2B RANBP2 SRSF4 DTL MTMR8 OBSL1 KANK2 SLC1A5 PREP ESPL1 ATP2B1 | 4.29e-08 | 974 | 214 | 23 | 28675297 |
| Pubmed | USP34 TBC1D9B SAAL1 EMC1 TUBGCP2 NUP205 EFTUD2 DNAAF5 DST MDN1 EIF2B5 TMX3 WDR77 HEATR3 RANBP2 MYO19 BTAF1 HNRNPUL1 SLC1A5 LGALS3BP EEF1G PIGT HOOK3 DOCK7 DYNC1LI1 ATM ARHGEF2 ATP2B1 | 8.11e-08 | 1440 | 214 | 28 | 30833792 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 RGPD1 TUBGCP2 RGPD3 PLRG1 RGPD2 RANBP2 RGPD8 THOC3 TBL3 DHX30 ARHGEF1 DYNC1LI1 ATM | 8.58e-08 | 370 | 214 | 14 | 22922362 |
| Pubmed | 9.57e-08 | 8 | 214 | 4 | 12435584 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES EMC1 MYO5C NUP205 EFTUD2 DST MDN1 VARS1 RANBP2 OBSL1 BTAF1 HNRNPUL1 SLC1A5 TBL3 LGALS3BP DHX30 EEF1G HOOK3 DOCK7 MACF1 CTNND1 ARHGEF2 ATP2B1 | 1.05e-07 | 1024 | 214 | 23 | 24711643 |
| Pubmed | USP34 CUL9 KPNA6 NELL1 DIP2A CORO2B DST PKD1 MLST8 WDR17 VARS1 CA11 PPP4R1 KALRN RAPGEF4 KCNAB2 OBSL1 SMG5 HNRNPUL1 KANK2 DHX30 ASB3 MACF1 ASTN1 ATM GEN1 | 1.14e-07 | 1285 | 214 | 26 | 35914814 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 1.19e-07 | 38 | 214 | 6 | 12791264 | |
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 17236128 | ||
| Pubmed | Associations of killer cell immunoglobulin- like receptor genes with rheumatoid arthritis. | 2.30e-07 | 3 | 214 | 3 | 22960345 | |
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 26430804 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 18292496 | ||
| Pubmed | 2.30e-07 | 3 | 214 | 3 | 30696053 | ||
| Pubmed | AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve. | 2.30e-07 | 3 | 214 | 3 | 23757022 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.95e-07 | 153 | 214 | 9 | 26365490 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 6.03e-07 | 79 | 214 | 7 | 12679517 | |
| Pubmed | NES KPNA6 NUP205 EFTUD2 DST PLD2 PLRG1 RANBP2 SRSF4 HNRNPUL1 THOC3 TBL3 DHX30 EGFR DOCK7 MACF1 CTNND1 | 8.34e-07 | 660 | 214 | 17 | 32780723 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 SAAL1 RGPD1 KPNA6 TUBGCP2 EFTUD2 PIGR RGPD3 PLRG1 WDR77 RGPD5 RGPD2 RANBP2 RGPD8 DTL HNRNPUL1 KANK2 LGALS3BP DHX30 DYNC1LI1 ZMYM1 ATM ESPL1 | 8.52e-07 | 1155 | 214 | 23 | 20360068 |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 8.86e-07 | 29 | 214 | 5 | 15203201 | |
| Pubmed | TUBGCP2 DNAAF5 EIF2B5 AKT2 VARS1 SLC1A5 TBL3 EGFR DYNC1LI1 CTNND1 ARHGEF2 ATP2B1 | 8.88e-07 | 323 | 214 | 12 | 24797263 | |
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 26528697 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 18091530 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 25375133 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 16929347 | ||
| Pubmed | 9.15e-07 | 4 | 214 | 3 | 9480752 | ||
| Pubmed | 1.33e-06 | 14 | 214 | 4 | 19875891 | ||
| Pubmed | 1.33e-06 | 14 | 214 | 4 | 19489269 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.33e-06 | 14 | 214 | 4 | 15896204 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | RGPD4 RGPD1 STK11IP EFTUD2 RGPD3 RGPD2 RANBP2 RGPD8 LGALS3BP ATP2B1 | 1.56e-06 | 226 | 214 | 10 | 37839992 |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 1.74e-06 | 33 | 214 | 5 | 25713288 | |
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.80e-06 | 15 | 214 | 4 | 17498266 | |
| Pubmed | 1.80e-06 | 15 | 214 | 4 | 20082646 | ||
| Pubmed | 1.80e-06 | 15 | 214 | 4 | 20356536 | ||
| Pubmed | 1.80e-06 | 15 | 214 | 4 | 19926642 | ||
| Pubmed | 1.80e-06 | 15 | 214 | 4 | 20643584 | ||
| Pubmed | 1.80e-06 | 15 | 214 | 4 | 19326408 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 18755860 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.28e-06 | 5 | 214 | 3 | 12629516 | |
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 26855332 | ||
| Pubmed | 2.28e-06 | 5 | 214 | 3 | 16112031 | ||
| Pubmed | CUL9 KPNA6 DNAAF5 DST MDN1 PIGR AKT1 AKT2 MYO19 PKP4 SMG5 DHX30 EGFR MACF1 ZMYM1 CTNND1 | 2.30e-06 | 634 | 214 | 16 | 34591612 | |
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 19897003 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 19309280 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.39e-06 | 16 | 214 | 4 | 16403292 | |
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 20652381 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 17868255 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 20331834 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 19000141 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 20670355 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 18668235 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 2.39e-06 | 16 | 214 | 4 | 19527230 | |
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 19279038 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 18643961 | ||
| Pubmed | 2.39e-06 | 16 | 214 | 4 | 20210919 | ||
| Interaction | RGPD2 interactions | 1.88e-10 | 27 | 205 | 8 | int:RGPD2 | |
| Interaction | RGPD4 interactions | 1.52e-09 | 22 | 205 | 7 | int:RGPD4 | |
| Interaction | RGPD8 interactions | 6.11e-08 | 74 | 205 | 9 | int:RGPD8 | |
| Interaction | COMTD1 interactions | TBC1D9B SAAL1 STK11IP NUP205 DNAAF5 EIF2B5 HEATR3 RGPD5 GPM6A RANBP2 BTAF1 HOOK3 INTS4 | 1.42e-07 | 200 | 205 | 13 | int:COMTD1 |
| Interaction | UNC93B1 interactions | SAAL1 EMC1 FNDC5 TUBGCP2 SPPL2B NUP205 DNAAF5 MDN1 EIF2B5 TMX3 HEATR3 SLC35C2 BTAF1 SLC1A5 EEF1G PIGT ATM ATP2B1 | 2.89e-07 | 417 | 205 | 18 | int:UNC93B1 |
| Interaction | TNFSF13B interactions | USP34 SAAL1 MDN1 EIF2B5 FAM118A HEATR3 RANBP2 BTAF1 PIGQ HOOK3 | 3.87e-07 | 119 | 205 | 10 | int:TNFSF13B |
| Interaction | RGPD3 interactions | 4.53e-07 | 47 | 205 | 7 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 6.08e-07 | 49 | 205 | 7 | int:RGPD1 | |
| Interaction | NPIPB6 interactions | 7.98e-07 | 18 | 205 | 5 | int:NPIPB6 | |
| Interaction | CD70 interactions | SAAL1 SPPL2B NUP205 DNAAF5 MDN1 EIF2B5 HEATR3 BTAF1 NR2F2 INTS4 ATM | 1.10e-06 | 166 | 205 | 11 | int:CD70 |
| Interaction | GPR45 interactions | TBC1D9B SAAL1 TUBGCP2 STK11IP NUP205 DNAAF5 MDN1 EIF2B5 MYO19 SPG11 BTAF1 MROH1 NFXL1 ATM | 2.57e-06 | 300 | 205 | 14 | int:GPR45 |
| Interaction | GPR182 interactions | SREBF2 TUBGCP2 NUP205 DNAAF5 MDN1 AP5Z1 PLD2 MLST8 MYO19 SPG11 BTAF1 VARS2 NR2F2 MROH1 NFXL1 ATM ATP2B1 | 4.43e-06 | 455 | 205 | 17 | int:GPR182 |
| Interaction | EEF1AKMT3 interactions | USP34 TBC1D9B CUL9 DNAAF5 EHBP1L1 MDN1 AKT1 DOCK6 RGPD5 ESPN SPG11 ARHGEF1 DOCK7 ARHGEF2 HPS5 | 5.13e-06 | 364 | 205 | 15 | int:EEF1AKMT3 |
| Interaction | UXS1 interactions | 5.26e-06 | 94 | 205 | 8 | int:UXS1 | |
| Interaction | NPTN interactions | FNDC5 DNAAF5 MDN1 AP5Z1 MLST8 GPM6A SPG11 BTAF1 PIKFYVE SPPL2A MROH1 ATM ATP2B1 | 5.77e-06 | 278 | 205 | 13 | int:NPTN |
| Interaction | CCDC8 interactions | CUL9 MYO5C NUP205 EFTUD2 DST MDN1 VARS1 RANBP2 OBSL1 BTAF1 SLC1A5 LGALS3BP DHX30 EEF1G HOOK3 DOCK7 MACF1 CTNND1 ARHGEF2 ATP2B1 | 1.31e-05 | 656 | 205 | 20 | int:CCDC8 |
| Interaction | HLA-C interactions | EMC1 KIR2DS2 TMEM131L KIR2DL2 KIR2DL3 ADGRL1 BTAF1 PIGT RNASE4 MROH1 EGFR KIR3DL3 INTS4 FBXW7 | 1.64e-05 | 353 | 205 | 14 | int:HLA-C |
| Interaction | FPR1 interactions | 2.01e-05 | 147 | 205 | 9 | int:FPR1 | |
| Interaction | TVP23C interactions | 2.19e-05 | 56 | 205 | 6 | int:TVP23C | |
| Interaction | ALDOA interactions | EMC1 FNDC5 EFTUD2 AKT1 PLD2 WDR77 KCNAB2 OBSL1 EGFR PREP INTS4 LTA4H FBXW7 | 2.66e-05 | 321 | 205 | 13 | int:ALDOA |
| Interaction | PTGER3 interactions | 2.81e-05 | 118 | 205 | 8 | int:PTGER3 | |
| Interaction | GPR17 interactions | TBC1D9B SAAL1 TUBGCP2 DNAAF5 MDN1 EIF2B5 HEATR3 SPG11 BTAF1 NR2F2 HOOK3 ATM | 3.49e-05 | 283 | 205 | 12 | int:GPR17 |
| Interaction | CD248 interactions | 3.52e-05 | 7 | 205 | 3 | int:CD248 | |
| Interaction | LMBR1L interactions | TBC1D9B SAAL1 EMC1 SREBF2 KPNA6 TUBGCP2 NUP205 DNAAF5 EIF2B5 TMX3 VARS1 HEATR3 RANBP2 FKRP DTL OBSL1 BTAF1 SLC1A5 TBL3 ARHGEF1 NFXL1 DYNC1LI1 ARHGEF2 ESPL1 | 3.60e-05 | 946 | 205 | 24 | int:LMBR1L |
| Interaction | GFPT1 interactions | 3.92e-05 | 160 | 205 | 9 | int:GFPT1 | |
| Interaction | FZD10 interactions | 5.63e-05 | 66 | 205 | 6 | int:FZD10 | |
| Interaction | RGPD5 interactions | 5.64e-05 | 96 | 205 | 7 | int:RGPD5 | |
| Interaction | PTPN3 interactions | 7.32e-05 | 100 | 205 | 7 | int:PTPN3 | |
| Interaction | RAC1 interactions | EMC1 PDE8A FNDC5 KPNA6 NUP205 EHBP1L1 DST MDN1 PTPRS C1QA AKT1 DOCK6 KALRN MYO19 PKP4 ADGRL1 SLC1A5 PIKFYVE USP6 EGFR DOCK7 MACF1 CTNND1 ARHGEF2 ATP2B1 | 8.35e-05 | 1063 | 205 | 25 | int:RAC1 |
| Interaction | TOP3B interactions | USP34 TBC1D9B CUL9 SPPL2B STK11IP DIP2A EHBP1L1 DST MDN1 PTPRS PKD1 AKT1 AKT2 DOCK6 RIC1 KALRN SZT2 MTMR8 MYOM3 ADGRL1 BTAF1 SMG5 KANK2 SLC1A5 NR2F2 DHX30 PIKFYVE MROH1 DIP2C ARHGEF2 ESPL1 | 8.59e-05 | 1470 | 205 | 31 | int:TOP3B |
| Interaction | C11orf52 interactions | FBXO17 DIP2A DST AKT2 DIP2B PKP4 SLC1A5 EGFR DOCK7 MACF1 CTNND1 ATP2B1 | 8.63e-05 | 311 | 205 | 12 | int:C11orf52 |
| Interaction | EPB41L4A interactions | 9.48e-05 | 140 | 205 | 8 | int:EPB41L4A | |
| Interaction | KLHDC9 interactions | 1.18e-04 | 10 | 205 | 3 | int:KLHDC9 | |
| Interaction | CDH5 interactions | 1.26e-04 | 109 | 205 | 7 | int:CDH5 | |
| Interaction | UBXN6 interactions | USP34 DNAAF5 EHBP1L1 DST MDN1 RGPD5 ESPN RGPD8 ARHGEF1 DOCK7 ARHGEF2 HPS5 | 1.31e-04 | 325 | 205 | 12 | int:UBXN6 |
| Interaction | EPHA1 interactions | USP34 SAAL1 NUP205 DST EIF2B5 HEATR3 SRSF4 BTAF1 NR2F2 DHX30 | 1.53e-04 | 235 | 205 | 10 | int:EPHA1 |
| Interaction | C9orf72 interactions | RGPD4 EMC1 RGPD1 KPNA6 NUP205 EFTUD2 MDN1 RGPD3 TMX3 PLRG1 WDR77 VARS1 RGPD5 RGPD2 RANBP2 RGPD8 DTL BTAF1 HNRNPUL1 THOC3 SLC1A5 TBL3 LGALS3BP DHX30 EEF1G NFXL1 DYNC1LI1 CTNND1 | 1.76e-04 | 1319 | 205 | 28 | int:C9orf72 |
| Interaction | DYRK1A interactions | USP34 FNDC5 KPNA6 NELL1 EIF2B5 AKT2 DOCK6 SRSF4 OBSL1 HNRNPUL1 KANK2 SLC1A5 EEF1G DOCK7 CTNND1 FBXW7 | 1.76e-04 | 552 | 205 | 16 | int:DYRK1A |
| Interaction | B3GALT6 interactions | 1.76e-04 | 28 | 205 | 4 | int:B3GALT6 | |
| Interaction | C3orf18 interactions | 1.76e-04 | 115 | 205 | 7 | int:C3orf18 | |
| Interaction | BTNL9 interactions | 2.00e-04 | 156 | 205 | 8 | int:BTNL9 | |
| Interaction | COPS3 interactions | KPNA6 FBXO17 EFTUD2 VARS1 DTL EEF1G EGFR DOCK7 DYNC1LI1 FBXW7 | 2.14e-04 | 245 | 205 | 10 | int:COPS3 |
| Interaction | NPAS1 interactions | NES TUBGCP2 DNAAF5 EHBP1L1 RGPD5 RGPD8 MYO19 SPG11 KANK2 ARHGEF1 | 2.14e-04 | 245 | 205 | 10 | int:NPAS1 |
| Interaction | CNTNAP2 interactions | 2.19e-04 | 158 | 205 | 8 | int:CNTNAP2 | |
| Interaction | C19orf38 interactions | 2.46e-04 | 86 | 205 | 6 | int:C19orf38 | |
| GeneFamily | WD repeat domain containing | WDR64 CORO2B TAF5 SPAG16 MLST8 WDR17 PLRG1 WDR77 WDR88 DTL THOC3 TBL3 FBXW7 | 2.68e-07 | 262 | 149 | 13 | 362 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.24e-05 | 18 | 149 | 4 | 620 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.67e-05 | 115 | 149 | 7 | 769 | |
| GeneFamily | F-box and leucine rich repeat proteins | 6.54e-04 | 21 | 149 | 3 | 558 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily F | 6.64e-04 | 5 | 149 | 2 | 916 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.38e-03 | 7 | 149 | 2 | 917 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.83e-03 | 8 | 149 | 2 | 939 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.19e-03 | 161 | 149 | 6 | 593 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 1.51e-09 | 43 | 207 | 8 | MM3857 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.09e-07 | 33 | 207 | 6 | MM477 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.76e-08 | 200 | 208 | 10 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-07 | 181 | 208 | 9 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-07 | 183 | 208 | 9 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.27e-07 | 199 | 208 | 9 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.45e-07 | 200 | 208 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.45e-07 | 200 | 208 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 185 | 208 | 8 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.64e-06 | 185 | 208 | 8 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.64e-06 | 185 | 208 | 8 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 185 | 208 | 8 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.64e-06 | 185 | 208 | 8 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.64e-06 | 185 | 208 | 8 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.64e-06 | 185 | 208 | 8 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.48e-06 | 192 | 208 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 198 | 208 | 8 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-06 | 198 | 208 | 8 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.70e-06 | 200 | 208 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 7.81e-06 | 153 | 208 | 7 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.13e-05 | 162 | 208 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.13e-05 | 162 | 208 | 7 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 1.67e-05 | 172 | 208 | 7 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 174 | 208 | 7 | 4289dfc7613db4bb3d706b9b65d06e84c0c53558 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 174 | 208 | 7 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 174 | 208 | 7 | 165e14cad57e90aa247dcecfaa3c2e8ff2a470ad | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-05 | 174 | 208 | 7 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-05 | 174 | 208 | 7 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 174 | 208 | 7 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 177 | 208 | 7 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-05 | 177 | 208 | 7 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 177 | 208 | 7 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 177 | 208 | 7 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-05 | 177 | 208 | 7 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-05 | 178 | 208 | 7 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-05 | 178 | 208 | 7 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 179 | 208 | 7 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-05 | 179 | 208 | 7 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 180 | 208 | 7 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 181 | 208 | 7 | cd46eba2e03fd15d8de8e875793ae2f51fa98b3b | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-05 | 181 | 208 | 7 | c7d12c7de227c9433ec2303b8929e957b833f59b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.32e-05 | 181 | 208 | 7 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-05 | 182 | 208 | 7 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.41e-05 | 182 | 208 | 7 | a035d45fd512bee8dac38eb387dbf39f5a8a1fed | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-05 | 184 | 208 | 7 | 1e54fd372c6e6a298f427b807c14cc49aaaffe80 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 2.58e-05 | 184 | 208 | 7 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-05 | 185 | 208 | 7 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.77e-05 | 186 | 208 | 7 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 186 | 208 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-05 | 186 | 208 | 7 | a417e1e21313a7e05951038cdef5ac672a9f727c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.96e-05 | 188 | 208 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.17e-05 | 190 | 208 | 7 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 191 | 208 | 7 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.28e-05 | 191 | 208 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.39e-05 | 192 | 208 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19-Myeloid-TRAM1|COVID-19 / Condition, Lineage and Cell class | 3.39e-05 | 192 | 208 | 7 | 52b8578699325b0d35a2d3ba36772096130ccc0c | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-05 | 193 | 208 | 7 | c9cf5a661294a947d06d53d18d47362c0e0b6ef5 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 3.50e-05 | 193 | 208 | 7 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.50e-05 | 193 | 208 | 7 | 8b2f89c3cf137315eed05d9edb5fc6011c5325a8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-05 | 193 | 208 | 7 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 194 | 208 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | COVID-19-Myeloid-TRAM2|COVID-19 / Condition, Lineage and Cell class | 3.62e-05 | 194 | 208 | 7 | c5bdf2b58c10dcb09797ddaf46b2e6c80d10399f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 194 | 208 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|CTRL / Disease state, Lineage and Cell class | 3.62e-05 | 194 | 208 | 7 | be69b20afa915978c4cf2feb0bb21ab7c1f301a5 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-05 | 194 | 208 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.66e-05 | 132 | 208 | 6 | 4e37400ae7375e6986f060234c373194603346f8 | |
| ToppCell | Bronchial_Biopsy-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.74e-05 | 195 | 208 | 7 | 6800c17026ec6c56132bf4664b8fcd74d7836579 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.74e-05 | 195 | 208 | 7 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 195 | 208 | 7 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 196 | 208 | 7 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 3.86e-05 | 196 | 208 | 7 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.86e-05 | 196 | 208 | 7 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | Control|World / Condition, Lineage and Cell class | 3.86e-05 | 196 | 208 | 7 | 2565f567c5274d1689e11600a2cb9e6770b65f74 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.99e-05 | 197 | 208 | 7 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Bronchial_Brush-Immune-Luminal_Macrophages|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.12e-05 | 198 | 208 | 7 | 77f41f0e0895b7c732bab1fd2e047f2ed31cbd9d | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 198 | 208 | 7 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.12e-05 | 198 | 208 | 7 | 8a21f885d26959b349eb4ca027328d6cf0f1b9cf | |
| ToppCell | critical-Epithelial-FOXN4+|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.12e-05 | 198 | 208 | 7 | 6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9 | |
| ToppCell | medial-Hematologic-Alveolar_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.12e-05 | 198 | 208 | 7 | d64f3d806594619607a72025a93b43ed4efaed01 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.12e-05 | 198 | 208 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | medial-2-Hematologic-Alveolar_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.12e-05 | 198 | 208 | 7 | ad8b9ac155737f794bf1974c59f8143c6ef63d71 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.12e-05 | 198 | 208 | 7 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 4.25e-05 | 199 | 208 | 7 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1+SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 4.25e-05 | 199 | 208 | 7 | 2cbaef86af870a228cb46895dd765ea8894c83c5 | |
| ToppCell | Mild-Myeloid-Macrophages-FABP4+|Mild / Condition, Lineage, Cell class and cell subclass | 4.25e-05 | 199 | 208 | 7 | 7bfd6ca4b0f2683715c24dfd7cf40418b5b8ddf2 | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.25e-05 | 199 | 208 | 7 | 2918967da22602404c767d948fed6c4754e53518 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.25e-05 | 199 | 208 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 4.25e-05 | 199 | 208 | 7 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.25e-05 | 199 | 208 | 7 | e1190b1c2d21fed313bb58e24d0e6365de6e6599 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-BMP_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.39e-05 | 200 | 208 | 7 | 01d707c4f8ee0daac635b7260937b1baebc6fc23 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-05 | 200 | 208 | 7 | 980cb0390586d8312890e8d0f3cf58e3309d16c5 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 4.39e-05 | 200 | 208 | 7 | 3b236900df407bf5a8c44e76d003a7a37d251db6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 200 | 208 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-05 | 200 | 208 | 7 | d7d971586c01152b3d21956fd98280588cb8f08b | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.51e-05 | 142 | 208 | 6 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.94e-05 | 148 | 208 | 6 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| Computational | Neighborhood of USP6 | 9.88e-05 | 70 | 115 | 6 | GCM_USP6 | |
| Disease | Colorectal Carcinoma | SPNS3 NELL1 CORO2B PTPRS PKHD1 OR1E2 AKT1 HTR5A KALRN ASAP3 CPE LGR5 ABCC6 SLC22A9 EGFR ARHGEF1 DIP2C RNF182 FBXW7 | 1.90e-07 | 702 | 192 | 19 | C0009402 |
| Disease | Malignant neoplasm of breast | TBC1D9B SREBF2 AKT1 AKT2 PLD2 KALRN WDR88 MTMR8 EPG5 OR12D3 SLC22A9 SLC39A12 HOOK3 EGFR DIP2C MACF1 ATM GEN1 RNF182 FBXW7 | 2.57e-05 | 1074 | 192 | 20 | C0006142 |
| Disease | combined oxidative phosphorylation deficiency 20 (implicated_via_orthology) | 4.21e-05 | 2 | 192 | 2 | DOID:0111478 (implicated_via_orthology) | |
| Disease | phosphatidylcholine 32:1 measurement | 1.08e-04 | 38 | 192 | 4 | EFO_0010373 | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 1.26e-04 | 3 | 192 | 2 | OBA_2042107 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.43e-04 | 16 | 192 | 3 | DOID:0110861 (implicated_via_orthology) | |
| Disease | X-11470 measurement | 2.43e-04 | 19 | 192 | 3 | EFO_0021241 | |
| Disease | Endometrial adenocarcinoma | 2.51e-04 | 4 | 192 | 2 | C1153706 | |
| Disease | Multiple congenital anomalies-hypotonia-seizures syndrome | 2.51e-04 | 4 | 192 | 2 | cv:C5191419 | |
| Disease | Adenocarcinoma of prostate | 2.85e-04 | 20 | 192 | 3 | C0007112 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 4.16e-04 | 5 | 192 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 4.19e-04 | 96 | 192 | 5 | C1319315 | |
| Disease | response to beta blocker, heart rate | 5.24e-04 | 57 | 192 | 4 | EFO_0004326, EFO_0007766 | |
| Disease | galectin-3-binding protein measurement | 6.21e-04 | 6 | 192 | 2 | EFO_0010241 | |
| Disease | neuroimaging measurement | PDE8A RGPD1 EFTUD2 NELL1 PKD1 PKHD1 MPST DIP2B TPCN2 SZT2 NR2F2 TG SLC39A12 EGFR ARHGEF1 MACF1 FBXL20 | 6.57e-04 | 1069 | 192 | 17 | EFO_0004346 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 7.67e-04 | 63 | 192 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | neuropilin-1 measurement | 8.66e-04 | 7 | 192 | 2 | EFO_0020603 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 8.66e-04 | 7 | 192 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 1.12e-03 | 315 | 192 | 8 | EFO_0004612, EFO_0008591 | |
| Disease | mitochondrial encephalomyopathy (implicated_via_orthology) | 1.15e-03 | 8 | 192 | 2 | DOID:890 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement, glucose tolerance test | 1.15e-03 | 8 | 192 | 2 | EFO_0004307, EFO_0008465 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.40e-03 | 74 | 192 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.47e-03 | 9 | 192 | 2 | C0085548 | |
| Disease | immunoglobulin M measurement | 1.47e-03 | 9 | 192 | 2 | EFO_0020466 | |
| Disease | endometrial cancer (is_implicated_in) | 1.65e-03 | 36 | 192 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | Tetralogy of Fallot | 1.83e-03 | 10 | 192 | 2 | HP_0001636 | |
| Disease | Moderate albuminuria | 1.87e-03 | 80 | 192 | 4 | HP_0012594 | |
| Disease | eye measurement, sun exposure measurement | 2.23e-03 | 11 | 192 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | placenta growth factor measurement | 2.23e-03 | 11 | 192 | 2 | EFO_0010626 | |
| Disease | venous thromboembolism, response to antineoplastic agent | 2.41e-03 | 41 | 192 | 3 | EFO_0004286, GO_0097327 | |
| Disease | mean corpuscular hemoglobin concentration | ADGRG5 HCAR2 EHBP1L1 ADGRF5 HEATR3 MPST KALRN GRB14 SMG5 HNRNPUL1 PIGQ EGFR ASB3 MACF1 FBXL20 RNF182 | 2.45e-03 | 1105 | 192 | 16 | EFO_0004528 |
| Disease | pulmonary tuberculosis (is_implicated_in) | 2.58e-03 | 42 | 192 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | response to radiation | 2.65e-03 | 88 | 192 | 4 | GO_0009314 | |
| Disease | squamous cell carcinoma, multiple keratinocyte carcinoma susceptibility measurement, basal cell carcinoma | 3.13e-03 | 13 | 192 | 2 | EFO_0000707, EFO_0004193, EFO_0007932 | |
| Disease | alcohol and nicotine codependence | 3.13e-03 | 13 | 192 | 2 | EFO_0004776 | |
| Disease | illegal drug consumption | 3.13e-03 | 13 | 192 | 2 | EFO_0005431 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 3.13e-03 | 13 | 192 | 2 | OBA_2045159 | |
| Disease | Connective Tissue Diseases | 3.13e-03 | 13 | 192 | 2 | C0009782 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.15e-03 | 45 | 192 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.15e-03 | 45 | 192 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | obsolete_red blood cell distribution width | HCAR2 RGPD1 EHBP1L1 DOCK6 HEATR3 CA11 MPST DIP2B KALRN MYO19 SMG5 THOC3 KANK2 EPG5 PIGQ ASB3 FBXL20 RNF182 | 3.16e-03 | 1347 | 192 | 18 | EFO_0005192 |
| Disease | central nervous system cancer, glioblastoma multiforme | 3.64e-03 | 14 | 192 | 2 | EFO_0000326, EFO_0000519 | |
| Disease | serum metabolite measurement | PDE8A PKD1L2 NWD2 DOCK6 MAP4K2 RIC1 SLC39A12 MROH1 DNAH17 DOCK7 DIP2C CSMD1 FBXL20 HPS5 | 3.70e-03 | 945 | 192 | 14 | EFO_0005653 |
| Disease | colorectal cancer (is_marker_for) | 3.72e-03 | 157 | 192 | 5 | DOID:9256 (is_marker_for) | |
| Disease | cannabis dependence measurement | 3.78e-03 | 48 | 192 | 3 | EFO_0008457 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.18e-03 | 15 | 192 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | 3-hydroxyanthranilic acid measurement | 4.18e-03 | 15 | 192 | 2 | EFO_0010447 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 4.18e-03 | 15 | 192 | 2 | EFO_0801746 | |
| Disease | Adenoid Cystic Carcinoma | 4.19e-03 | 100 | 192 | 4 | C0010606 | |
| Disease | Polyposis, Adenomatous Intestinal | 4.76e-03 | 16 | 192 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 4.76e-03 | 16 | 192 | 2 | C2713443 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 5.22e-03 | 321 | 192 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | Small cell carcinoma of lung | 5.27e-03 | 54 | 192 | 3 | C0149925 | |
| Disease | Adenomatous Polyposis Coli | 5.37e-03 | 17 | 192 | 2 | C0032580 | |
| Disease | MHPG measurement, 5-HIAA measurement | 5.37e-03 | 17 | 192 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.37e-03 | 17 | 192 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | peptide measurement | 5.68e-03 | 109 | 192 | 4 | EFO_0010520 | |
| Disease | Epilepsy | 5.68e-03 | 109 | 192 | 4 | C0014544 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 5.84e-03 | 56 | 192 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Malignant neoplasm of endometrium | 6.02e-03 | 18 | 192 | 2 | C0007103 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 6.02e-03 | 18 | 192 | 2 | OBA_2045155 | |
| Disease | Carcinoma in situ of endometrium | 6.02e-03 | 18 | 192 | 2 | C0346191 | |
| Disease | urate measurement, spine bone mineral density | 6.44e-03 | 58 | 192 | 3 | EFO_0004531, EFO_0007701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRELVTGVLWNLSSC | 631 | Q99569 | |
| NTFIIRCLQWTTVIE | 71 | P31749 | |
| NTFVIRCLQWTTVIE | 71 | P31751 | |
| ESQLWLCVQLVAIAI | 186 | P54793 | |
| WSVCEQIGVTTCSII | 391 | Q6ZRH7 | |
| CDRSLLSSLVSWIVA | 1201 | Q9HCE0 | |
| ILAVDWLVDRSCTVL | 456 | Q15758 | |
| VAQTVSERKNWCALI | 741 | Q92888 | |
| LWTAICNRDLLSVLE | 551 | Q8TDY4 | |
| LVWEECVANSAVILQ | 241 | O71037 | |
| LVWEECVANSAVILQ | 241 | Q902F8 | |
| SITCQRVTETLAAWS | 386 | Q96PZ7 | |
| LSQWEICLSIVSSSR | 166 | P02745 | |
| AVALTSWISDRLLCS | 181 | Q8TDN7 | |
| GWQVIRETCVLSLLE | 291 | Q5T601 | |
| WLLTNPTETAQTRCI | 2401 | Q8IZF6 | |
| AVLWNLCVTAVLVTS | 6 | O94910 | |
| TWIRVIQQSVRTCPS | 561 | Q92974 | |
| EQLRCLQALSWLTSS | 856 | Q6TFL3 | |
| CTSQIEFSLWSLRQI | 1006 | Q7Z2Y8 | |
| LCSRASLVTSVVWAI | 636 | O43299 | |
| CSETVTWILIDRALN | 246 | O75493 | |
| IATCSDDNTLKIWRL | 376 | Q9NZJ0 | |
| ELWTSVDVLCVTASI | 111 | P13945 | |
| TKVSCLETVWVSRAN | 761 | Q7L2E3 | |
| LSVVCVVLVTAFNDW | 161 | P20020 | |
| TQRLLQEATMSSLWC | 986 | O14525 | |
| ETVNIWSLTDEVICR | 1501 | Q9ULI1 | |
| ALRSSLEWNSCVVQT | 196 | P49792 | |
| ALRSSLEWNSCVVQT | 196 | Q99666 | |
| ALRSSLEWNSCVVQT | 196 | O14715 | |
| VVLAQSVENVWTTCR | 711 | Q4ADV7 | |
| RLTWSELFVLNAAQC | 246 | P24468 | |
| TAWTEACQVEVRLLL | 901 | Q96HW7 | |
| SEETVILQCWSDVRF | 41 | P43631 | |
| TIITWSENARLALCE | 606 | Q92621 | |
| TNACIALSQRWITAK | 466 | P09960 | |
| IETVVCLQDSVLAFW | 746 | Q12851 | |
| SQWVLRGAEVVLTCR | 136 | O75147 | |
| SIRKEACWTISNITA | 351 | O60684 | |
| SEETVILQCWSDVRF | 41 | P43627 | |
| RKCVVSIRDILSWVN | 1596 | Q9NU22 | |
| VTITCRASQGISSWL | 41 | P01611 | |
| NLWDLTDASVVCRAL | 51 | Q08380 | |
| LICIASVKRNQAVWS | 161 | Q6ZNB6 | |
| SEETVILQCWSDVRF | 41 | P43628 | |
| GWDRTAQVCSVASIL | 341 | Q96EF0 | |
| RLFDWLVSVINSSIC | 386 | Q96H55 | |
| NRTAAIISCLLWGIT | 141 | Q8TDS4 | |
| WTCVSTENLVVAGLL | 151 | Q9H427 | |
| TRWETVCALSISKQT | 6901 | Q03001 | |
| FNLWTICRNTTLVEG | 156 | P51674 | |
| TRRNSAIVCAGVWIL | 151 | Q99677 | |
| TCRGALISDQWVLTA | 491 | P06681 | |
| VIVWLVSCTDVSLSE | 221 | B1AK53 | |
| VTALCWDTAILRVFV | 126 | Q9UPZ3 | |
| QNLWSCILSEVSTRS | 46 | Q9Y6G9 | |
| WCRPTSLNVVRIITS | 111 | Q13144 | |
| VTASSDNLARLWCVE | 286 | Q9BVC4 | |
| DVLVTCSRDSTARIW | 301 | O43660 | |
| ETWCSVRPTVILRDT | 381 | Q9H5P4 | |
| VEESALCLELLWTVQ | 56 | P51160 | |
| LHCSESTLRSWLQII | 531 | O60658 | |
| SGETVILQCWSDVRF | 136 | Q8N743 | |
| CSSILQTEERNWVSV | 261 | P55259 | |
| IAQERSCTSVILRWL | 2576 | O60229 | |
| AECAVFTWTNLLVVV | 1491 | Q9P265 | |
| LVSSSQSLLEWCQEV | 1036 | Q8N3D4 | |
| CARAWLSSQVAELER | 121 | P48681 | |
| QELSTRWDTVCKLSV | 2871 | O94854 | |
| IIWVLCAVAATLVSH | 331 | Q9H3U5 | |
| VERQLCSVWISNKTA | 651 | Q9BSJ2 | |
| LAWCSRINSVTTDNI | 436 | Q6W3E5 | |
| LVDTVFNTVWTLGCR | 161 | Q9BX93 | |
| SLERAELCESLLTWI | 6 | Q86VS8 | |
| ELCESLLTWIQTFNV | 11 | Q86VS8 | |
| LRDTLAIISDNAWIC | 611 | Q8NDA8 | |
| AIISDNAWICQLSLE | 616 | Q8NDA8 | |
| RQAAAVCAVLWVLVI | 131 | Q9HC97 | |
| LVWEECVANSAVILQ | 1001 | P63135 | |
| ILVVWFCVCTARTVV | 6 | Q92832 | |
| TNLSVSVENLCTVIW | 36 | P78552 | |
| LAIAWCLRNEGVSSV | 306 | Q13303 | |
| ITNCVTSSINVSRAW | 401 | Q7Z2Q7 | |
| WSIFSSVTCRKAVLD | 11 | Q7Z6M3 | |
| ALWSSCVERQLLRTD | 601 | Q7Z442 | |
| KCVSVRSTAILVSWR | 626 | Q13332 | |
| ACSDTLLNQWLLSIV | 186 | Q9UGF7 | |
| NISELISFSWLSVLC | 336 | Q96QZ0 | |
| DVLEWIACVRSNFLV | 336 | P48147 | |
| TSFEWCSKRQLVDLV | 151 | Q96EF6 | |
| ALRSSLEWNSCVVQT | 196 | A6NKT7 | |
| SSWRDIIVSLVCQVV | 631 | Q9Y2I7 | |
| LCNVESIQWRDIVSS | 156 | P00533 | |
| SWRSCIEAVIEAAEQ | 51 | Q9NWS6 | |
| RLCSLWLENSGVSEV | 2486 | Q13315 | |
| LILLCNSWIDSVSID | 406 | Q9Y575 | |
| WQVLSEVLSCSEKLV | 981 | Q14674 | |
| VLWNICECSSRAVSI | 166 | Q7Z4Q2 | |
| TLDSGWLTCQTEIRL | 121 | Q9NPB8 | |
| NIIASCSEDTSVRIW | 101 | Q9UQ03 | |
| SAESSRTLLACVLWV | 1246 | Q96HP0 | |
| LQWVVCSGSVRESAL | 991 | Q96N67 | |
| RISVALVICEWAALQ | 726 | O14981 | |
| IAKVLDTICFIWATS | 311 | Q9UFH2 | |
| LVWEECVANSAVILQ | 241 | P61570 | |
| LVWEECVANSAVILQ | 241 | Q69384 | |
| SLEFLQSRCTLVQWL | 336 | Q9UKA2 | |
| VVWRIRASNTKLVCA | 671 | Q969H0 | |
| EALVSVWLQCTAISR | 61 | P16870 | |
| TECAVFTWTNLLVVV | 1471 | Q9Y2E4 | |
| DVLCCTASIWNVTAI | 121 | P47898 | |
| SCRKIAQLAVSWQAT | 351 | Q5T2N8 | |
| IWLDNVQCRGTESTL | 481 | Q9UEW3 | |
| AVEVRSLSSLWLLCN | 396 | Q96T53 | |
| EKTFETLCTVRTWIL | 546 | O75899 | |
| TIAVDLSLWVCEAQT | 26 | Q17RS7 | |
| TTVLQEWLRLACRSD | 621 | Q63ZY3 | |
| EEQSRTCWVTAIRLL | 326 | Q14449 | |
| VTITCRASQGISSWL | 41 | A0A0C4DH73 | |
| SSSLRNITQCWLSVV | 1466 | Q8IWT3 | |
| RVTLADITVVCTLLW | 156 | P26641 | |
| LVWEECVANSAVILQ | 241 | Q902F9 | |
| VLWSREESLAEVVCL | 441 | Q8N766 | |
| AAIRTAAVSCLWALT | 671 | Q86Y56 | |
| AAVSCLWALTSSEVL | 676 | Q86Y56 | |
| AECAVFTWTNLLVVV | 1486 | Q14689 | |
| ELVTRINSWCTRLID | 471 | Q9H069 | |
| ARCLALNVSLREWTA | 166 | Q9H9S5 | |
| LTCLSQAEVASVWVE | 161 | Q96ER3 | |
| ELDQLLNTLWTRSTC | 251 | Q504Y0 | |
| IEWESVLTNTAGCLR | 521 | O60716 | |
| STCAWAIVQVEISRC | 161 | Q86WN2 | |
| RIGVWTIAVLALTCN | 561 | O75473 | |
| SVFLSCSEDNRILLW | 181 | Q9BQA1 | |
| LLVSSCVDSLWSVAQ | 4046 | P98161 | |
| CVDSLWSVAQALLVL | 4051 | P98161 | |
| VTALRALSFCSWVRT | 291 | Q96A99 | |
| LACSDTRVNEWVIFI | 196 | P47887 | |
| LSVLRLACADTWLNQ | 181 | Q8NGT9 | |
| IALRSSLEWNSCVVQ | 186 | P0DJD0 | |
| VVRIGWSLDSCSTQL | 281 | Q9BUJ2 | |
| GEASTCWQLTVRVLE | 16 | Q86XP0 | |
| SRISWIISICVFVLT | 61 | O15403 | |
| NTAIIWVVCTHSTLR | 46 | Q8NGQ4 | |
| QLAIAWCLRSEGVSS | 346 | O43448 | |
| STRLVNWSCTLNSAI | 471 | P26640 | |
| LVNWSCALRSAISDI | 276 | Q5ST30 | |
| TVRLWSLQTFTCLVG | 566 | Q15542 | |
| LESVINTACFTLWTR | 3416 | Q5T011 | |
| FWALRVVCQEQLTAL | 1046 | Q8N1F8 | |
| VVCQEQLTALLAWIR | 1051 | Q8N1F8 | |
| ALRSSLEWNSCVVQT | 196 | Q7Z3J3 | |
| WVVTEICLCSQLSKR | 826 | Q8WZA2 | |
| LIVENLSSRCSWQDL | 106 | Q08170 | |
| LCRALVSAQWVAEAL | 6 | P25325 | |
| ALNLCADKVSSVRWI | 786 | Q8TF05 | |
| SLWVSRVAQIAVLCV | 61 | Q8N4K4 | |
| LIIVCAQSSQSLWNR | 671 | Q9UPR3 | |
| RSELSSDINVRSWCI | 1246 | A2VDJ0 | |
| SVEQIWITVLQCRDL | 236 | Q8N9U0 | |
| VLCTSSVAVALWKIQ | 81 | O95255 | |
| LRSSLEWNSCVVQTL | 196 | P0DJD1 | |
| IVTEWDLVCDSQSLT | 131 | Q8IVM8 | |
| DVVTLCRCAQVSRAW | 41 | Q96IG2 | |
| QEVNTTTRSCALWDL | 81 | Q8NAU1 | |
| RLSATATKVVICVIW | 141 | P25103 | |
| SLVSAVSACRVFKLW | 221 | Q9BRB3 | |
| LRSLSICWHSSRVQV | 71 | Q6P050 | |
| SRVQVCSIEDWLKSA | 81 | Q6P050 | |
| AQSLNTWLILCSDRT | 481 | Q7Z3Z4 | |
| WCTDQVIVQRTLAAK | 286 | Q8WWX8 | |
| CSRDSTVRLWSLTAL | 671 | Q8IZU2 | |
| ALVWVLVGNRSCDIV | 1226 | P08F94 | |
| WNCTSLLFQTSIRVL | 171 | Q8N6D2 | |
| WCISFEQILASILTE | 1196 | Q66K14 | |
| LVCEKEVLSSNVSWR | 291 | Q8IZF2 | |
| LCLLTLQNATTETWE | 11 | Q8IZF4 | |
| LLIAFICVRSSLWTN | 56 | Q96FZ5 | |
| SINLACVVVSRDWLS | 16 | Q8TAT8 | |
| LCVWIITSVEDNVAT | 1486 | Q96JI7 | |
| SWTALRLCATVVVLD | 6 | Q96JJ7 | |
| EDIWNIRSICSTTNI | 76 | P34096 | |
| ACTWSALALSVRVAT | 66 | A0A0J9YY54 | |
| DRCIKIWDVTSQATL | 251 | Q6ZMY6 | |
| TLVCQVDQATAWERL | 41 | Q96BF3 | |
| SSAAQLLICLTWLVV | 686 | Q7RTX1 | |
| LSWVASQEDTNCILL | 96 | Q9NYP9 | |
| CTSISWELRQTLSVV | 231 | Q969N2 | |
| LSCNWAVVADILLSV | 381 | Q6ZMD2 | |
| LNQTGITWAEVLRCV | 211 | Q15813 | |
| AIRVWSLQDRSCLAV | 176 | Q12788 | |
| CTLITASVVAWRRKE | 471 | Q8TCT8 | |
| TLVTSCAVALWRREL | 481 | Q8TCT7 | |
| TLSIWDARTGICEQS | 501 | Q8N0X2 | |
| SRLDLACSLSWNVIR | 611 | Q12772 | |
| QRWSLTLSLRLECSS | 26 | Q96PS6 | |
| IWDVRTTKCIATVNT | 126 | Q96J01 | |
| LASSVCTVWTCVIIV | 981 | Q9H5I5 | |
| LVQCSSHRARVVLSW | 66 | Q9NQQ7 | |
| EWTLAEASVVCRQLG | 56 | Q4G0T1 | |
| CRKWITTETSIITQL | 171 | Q70EL3 | |
| TVREGQLVNLTCLVW | 1096 | Q9BZZ2 | |
| CLTNGDTLWRTTVEI | 441 | P01833 | |
| AWCCLDFIIVIVSVT | 1121 | Q9UI33 | |
| QSCWTVHDRTLLSVI | 806 | Q5SVZ6 | |
| CWTTLISAFRILLES | 2941 | Q70CQ2 | |
| DSQICTVGRLWISVA | 521 | Q15029 | |
| DAIWNSRKIVCLVSR | 746 | O60602 | |
| SCVISSVGANEIWVR | 286 | Q9H7L9 | |
| WCTDQVIVQRCLSAK | 291 | P13866 | |
| TIIASQWVLTVAHCL | 141 | Q9UI38 | |
| VTLSSNWILGVCRDS | 346 | A6NI03 | |
| EIFTLLASICWVSAN | 6 | P01266 | |
| CTTVQVLRSVDRWSA | 601 | O14939 | |
| TTVEVAWCELQTRKL | 196 | Q96J92 | |
| SCWVRAISQEDQLAT | 476 | P35125 | |
| VVSLVDWTVSLSLVC | 166 | Q8NHX9 | |
| ERSQVSTNSHVCLLW | 241 | Q9BXU2 | |
| LTICSESIIRVWELE | 471 | B1ANS9 | |
| RVQWSGCSAVTCILE | 306 | A8MPX8 | |
| VTITCRASQGISSWL | 41 | P01601 | |
| QWLCNRKIVTSSETV | 371 | Q9NQX4 | |
| WEHTTVLLTCTVQAS | 166 | Q5VTT5 |